Adams-Stokes syndrome caused by sinoatrial block.

Sigurd, B; Jensen, Gorm; Meibom, J; Sandøe, Erik

doi:10.1136/hrt.35.10.1002

Cited by 27 publications

(8 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[8][9][10][11][12][13][14][15][16] Hypertension (78.20%) was the most common associated co-morbidity and 23.07% patients were diabetic, consistent with previous studies. …”

Section: Discussionsupporting

confidence: 83%

Clinical profiles of patients undergoing pacemaker implantation in India

Jain¹

2018

jmscr

View full text Add to dashboard Cite

“…[8][9][10][11][12][13][14][15][16] Hypertension (78.20%) was the most common associated co-morbidity and 23.07% patients were diabetic, consistent with previous studies. …”

Section: Discussionsupporting

confidence: 83%

Clinical profiles of patients undergoing pacemaker implantation in India

Jain¹

2018

jmscr

View full text Add to dashboard Cite

“…The major symptoms (syncopes, dizziness, palpitations and dyspnoea) are either due to the block or to the often concomitant attacks of tachyarrhythmias. Medical treatment alone is often not enough and permanent pacing alone or in combination with antiarrhythmic drugs may be the only satisfying way to treat the patients ( 2 , 4, 5, 6, 10,11,12).…”

mentioning

confidence: 99%

The Long‐term Prognosis for Patients with Sinoatrial Block Treated with Permanent Pacemaker

Skagen

Hansen

1976

Journal of Internal Medicine

View full text Add to dashboard Cite

Fifty patients with SA block have been treated with permanent pacing and followed up for 1-14 years. Survival after one, two, five and eight years was calculated to 94, 85, 64 and 48%, respectively. These figures indicate an excess yearly mortality in the first five years of 4 5 % compared with a population of the same age and sex. Analysis of the survival curves shows that the excess mortality is caused by coexisting diseases, primarily coronary heart disease with previous myocardial infarction and valvular heart disease.

show abstract

“…It appears that the tendency to progress to atrial fibrillation in the former group, and the associated systemic and pulmonary emboli that may result from intermittent tachycardias, increase morbidity and mortality. These patients also tend to exhibit more severe peripheral and coronary arterial disease 14 . Recent evidence suggests, however, that atrial pacing in AAI and AAIR modes reduces morbidity and mortality by decreasing the incidence of atrial fibrillation and peripheral embolisation as well as improving congestive cardiac failure compared to ventricular pacing 15 , 16 …”

Section: What Are the Indications For Permanent Cardiac Pacing?mentioning

confidence: 99%

Which Pacemaker?

Sulke¹

1991

Int J Clinical Practice

View full text Add to dashboard Cite

INTRODUCTION The first fully implantable cardiac pacemaker was inserted by Elmqvist and Senning in 19591 into an electrical engineer suffering from complete atrioventricular (AV) block. He is still alive today. Since then, and more specifically in the last decade, cardiac pacing has been transformed by technological innovation, and has resulted in devices that no longer merely prevent the incidence of syncope and sudden death in patients with complete heart block, but actually restore appropriate chronotropic response to exercise, and maintain normal conduction between, and contraction of, the cardiac chambers. Modern ‘physiological’ pacemakers are thus designed to restore a normal quality of life to patients requiring cardiac pacing.

show abstract

Adams-Stokes syndrome caused by sinoatrial block.

Cited by 27 publications

References 12 publications

Clinical profiles of patients undergoing pacemaker implantation in India

Clinical profiles of patients undergoing pacemaker implantation in India

The Long‐term Prognosis for Patients with Sinoatrial Block Treated with Permanent Pacemaker

Which Pacemaker?

Contact Info

Product

Resources

About